Fletcher, North Carolina, November 18, 2019 – Capstone has partnered with bioMerieux Inc. to offer the innovative AGILIST ™ Advanced Analytic Platform to Capstone members. The AGILIST platform is a clinical informatics tool, focused on empowering diagnostic stewardship and optimizing microbiology operations and infectious disease management. AGILIST helps addresses unmet needs in today’s siloed healthcare environment, empowering laboratorians, clinicians, and healthcare executives to drive evidence-based decisions to improve patient care, quality initiatives and resource utilization. Furthermore, this offering represents a pioneering approach for Capstone early adopters in support of the fight against antimicrobial resistance.
About Capstone Health Alliance
Capstone Health Alliance is a group purchasing alliance of healthcare members that delivers real cost savings through the power of aggregation and collaboration. Based in Fletcher, North Carolina, Capstone represents over $9 billion in acute care supply chain spend. To create the best savings opportunities for our members, we pair Premier’s national portfolio with our local aggregation model – blending the best of national and regional contracting – to continually expand our extensive portfolio of more than 750 preferred pricing agreements. Capstone delivers quantifiable savings and actionable data that enable better supply chain decisions for our member facilities. In addition to cost savings initiatives, Capstone members collaborate to share best practices and pursue resource utilization initiatives, all with the intent of improving cost, quality, and outcomes in patient care.
A world leader in the field of in vitro diagnostics for over 55 years, bioMérieux is present in 43 countries and serves more than 160 countries with the support of a large network of distributors. In 2018, revenues reached €2.4 billion, with over 90% of international sales. bioMérieux provides diagnostic solutions (systems, reagents, software and services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
bioMerieux & Antimicrobial Stewardship in the U.S.
Antimicrobial Resistance (AMR) is one of today’s most serious global threats to human health, and bioMerieux knows health systems can provide the solution to diminish AMR through proper Antimicrobial Stewardship. Partnering with bioMérieux provides access to our integrated offer of diagnostic products, clinical consulting and AGILIST ™ Advanced Analytic Platform. Working as a team brings operational efficiencies, improved patient outcomes and a solid, positive impact to the organization’s bottom line.
bioMérieux is the trusted partner that healthcare systems today need to confidently deliver evidence-based clinical outcomes that support their stewardship program. Helping organizations to discover the dynamic insights that drive action for informed decision making through our new three-pronged approach with consultancy services, data analytic platform and products.